Information  X 
Enter a valid email address

Lifeline Scientific (LSI)

  Print      Mail a friend

Wednesday 12 August, 2009

Lifeline Scientific

LifePort Recognised as Key Me

RNS Number : 2753X
Lifeline Scientific, Inc
12 August 2009
 




12 August 2009

Lifeline Scientific, Inc

('Lifeline' or 'the Company')


LifePort Recognised as Key Medical Device


Lifeline Scientific, the medical technology company focused on commercialising its LifePort® Kidney Transporter, an advanced organ preservation and transport system, designed to address the global challenge of human donor organ shortages, announces that Medical Device & Diagnostic Industry ('MDDI') magazine has recognised the LifePort® Kidney Transporter as one of the top medical devices of the past 30 years.


In celebration of their 30th anniversary MDDI magazine honored the top 30 medical devices from the past 30 years. The LifePort® Kidney Transporter made the list and stands among many groundbreaking medical inventions including the Blood and Cell Separator and the Angioplasty Balloon Catheter.  MDDI praised the LifePort by saying: 'The product uses mobile machine perfusion to improve transplant outcomes, allowing the use of more organs and lowering the number of organs discarded.'


David Kravitz, Chief Executive of Lifeline, said:


'It is a tremendous achievement for the LifePort to be recognised alongside those devices that have helped shape medicinal practice over the past 30 years. LifePort is off to a strong start and we are grateful for the opportunity to help advance transplant medicine worldwide.'  

    


Enquiries

Lifeline Scientific, Inc.

+1 847 294 0300

David Kravitz, CEO


Seymour Pierce (Nomad)

+44 (0)20 7107 8000

Mark Percy / Huaizheng Peng / Sarah Jacobs


Financial Dynamics

+44 (0)20 7831 3113

Ben Brewerton / John Dineen

 

 

About the LifePort Kidney Transporter

Created with the challenges of organ recovery and transport in mind, LifePort Kidney Transporter is designed to provide improved kidney preservation, evaluation and transport prior to transplantation. LifePort provides a sealed, sterile, protected environment where a solution is gently pumped through the kidney at cold temperatures to minimize damage while the organ is outside the body. LifePort is lightweight and portable, allowing organs to be perfused from the time of recovery until transplant. It is designed to travel unaccompanied by land or air, safely transporting the kidneys across town or between countries. While the kidney is being perfused, the LifePort records data on temperature, flow rate, vascular resistance and pressure every 10 seconds providing surgeons with additional data prior to transplant. During its pilot introduction, approximately 315 LifePorts have been installed in 90 transplant programs worldwide treating more than 17,000 kidneys.

 

About Lifeline Scientific Inc.  

Lifeline Scientific, Inc. is a Chicago-based global medical technology company with European headquarters located in Brussels. Its primary focus is to commercialise the FDA approved, CE marked, clinically validated and revenue generating LifePort Kidney Transporter. LifePort devices for preservation of the heart, lung, pancreas and liver are in pre-clinical development. 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPBMATMMJBBPL